This course has expired. You can still review the content but course credit is no longer available.
Sponsored by an educational grant from Regeneron Pharmaceuticals, Inc., and Carl Zeiss Meditec, Inc.
Upon completion of this activity, the participant should be able to:
Evolve is an approved COPE Administrator
This course is COPE approved for 1.25 hours of CE Credit for Optometrists:
COPE Course ID: 65397-PS
COPE Activity ID: 118502
The following faculty/staff members have the following financial relationships with commercial interests:
David Eichenbaum, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Genentech, Regeneron, Allergan, Clearside, Novartis, Alimera, Notal Vision, Allegro, EyePoint, Orbit Biomedical, Adverum, Kodiak; Speaker: Genentech, Allergan, Novartis, Notal Vision; Investigator: Genentech, Allergan, Clearside, Novartis, Alimera, Ophthotech, Opthea, Mylan, Chengdu, Kodiak; Equity/Stockholder: Clearside, US Retina, Hemera Biopharmaceuticals, Boston Image Reading Center.
Editorial Support Disclosures
Erin K. Fletcher, MIT, director of compliance and education, Evolve and Susan Gallagher-Pecha, director of client services and project management, Evolve, have no financial relationships with commercial interests. Jaya Kumar, MD, peer reviewer, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Regeneron Pharmaceuticals, Inc. or Carl Zeiss Meditec Inc.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.